Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
CHIO3: CHemotherapy combined with immune checkpoint inhibitor for operable stage IIIA/B (N2) Non-Small cell lung cancer (AFT-46).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 30, 2025
Can Molecular Biomarkers be Utilized to Determine Appropriate Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC)?
Journal: Journal of cellular immunology
Published: July 03, 2024
Use of UV mutational signatures to distinguish between cutaneous and pulmonary primary squamous cell carcinoma.
Journal: Journal of cutaneous pathology
Published: March 09, 2024
A giant peritoneal mesothelioma extending to the pelvic floor: A case report and review of the literature.
Journal: Journal of cancer research and therapeutics
Published: January 31, 2024
Breast Cancer Treatment: To tARget or Not? That Is the Question.
Journal: Cancers
Published: October 23, 2023
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data.
Journal: Clinical lung cancer
Published: March 14, 2023
Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma.
Journal: Frontiers in oncology
Published: February 19, 2023
Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer.
Journal: Frontiers in oncology
Published: December 30, 2022
Radioimmunoconjugates in the age of modern immuno-oncology.
Journal: Life sciences
Published: September 15, 2022
The Lung Microbiota and Lung Cancer: A Growing Relationship.
Journal: Cancers
Published: June 10, 2022
Last Updated: 09/26/2026